Base to Base Biotech
The Base to Base Biotech podcast is a weekly look at what's happening in the world of biotech, with interviews with biotech leaders around the world. Whether it's a new drug, cutting-edge technology, product launches, new technology, major finding announcement or clinical trial results, Base to Base Biotech keeps you informed. The podcast is hosted by former biotech editor and broadcaster, the award-winning media veteran Jim Cornall. Base to Base is an Ayr Coastal Media Ltd production.
Episodes
This week, we have conversations with Jérôme Van Biervliet, chair of the board of Flanders life sciences body Biovia and managing director at VIB; Sylvain Sachot, partner at Asabys Partners; and Jonas Béal, head of science strategy, R&D, at Owkin.
03:32 Owkin
27:42 Biovia/VIB
38:06 Asabys Partners
Biovia/VIB
Biovia has emerged as a new health innovation cluster in the Belgian region of Flanders, created through the merger of flan...
This week, we have conversations with Robert Bunn, founder and president of Ultrasound AI; Laura MacNeill, CEO of the Charcot Marie Tooth Research Foundation; and Iris Örhn, investment advisor at Business Region Göteborg.
03:00 Ultrasound AI
30:19 Business Region Gothenburg
39:35 CMTRF
Business Region Gothenburg
Business Region Gothenburg (BRG) is the regional development agency for western Sweden, tasked with driving growth and innov...
This week, we have conversations with Malin Kjällström, Gothenburg Tech Week Press and partnerships lead; Eliot Forster the CEO of Levicept; and Christophe Demaison, CEO of ENA Respiratory.
Gothenburg Tech Week
Gothenburg Tech Week is western Sweden’s largest technology event, held annually across multiple venues in the city. The 2025 edition ran from October 14–16, with a programme that includes startup and investor matchmaking, the...
It’s World Immunization Day on Monday, so we had a chat with Geovax chairman, president and CEO David Dodd, and in our other conversation, we talked about infertility, with Igyxos Biotherapeutics’ chief medical officer Elke Bestel.
Challenging infertility
Igyxos Biotherapeutics is a French biotechnology company founded in 2017 and based in Nouzilly, France. The company focuses exclusively on infertility, developing monoclonal antibod...
This week, we have conversations with Cosmo Feilding Mellen, CEO of Beckley Psytech; Sirli Rosenvald, CEO of Estonian company Funki, and Per von Mentzer, CEO of Swedish company PharmNovo. We spoke with Funki at Life Sciences Baltics in Vilnius, Lithuania, recently, and with von Mentzer at NLS Days in Gothenburg.
Taking on pain
PharmNovo AB is a biotechnology company headquartered at Medicon Village in Lund, Sweden. Founded in 2008, i...
This week, we have conversations on data integration with Lithuanian company Vugene, and we talk protein degradation with Amphista Therapeutics.
Multi-omics
Vugene is a Lithuanian bioinformatics company focused on multi-omics data integration. Founded in 2021 by CTO Juozas Gordevičius, the company is headquartered in Kaunas.
Its core offering is a software platform designed to help researchers make sense of complex biological datasets...
This week, we have one interview, covering enzymes and AI with Biomatter Designs, from our visit to Life Sciences Baltics in Vilnius, Lithuania recently. And from the trip to Dublin in Ireland we talked about technology that can be useful in neurological condition diagnosis, and much more, with Danu Sports.
Enzymes and AI
Biomatter Designs is a Lithuania‑based biotech working at the frontier of protein design. Since its launch in 201...
This week, we have three interviews done during Life Sciences Baltics, which was held in Vilnius, Lithuania recently.
While we have more still to come, this week on the podcast we have conversations with Justinas Mačiulaitis, Keli Therapeutics’ founder and CEO; Arnas Karužas, CEO of Ligence; and Emilė Radytė, CEO and co-founder of Samphire Neuroscience.
Ligence
Ligence is a health‑tech startup using artificial intelligence to automat...
This week, we have two interviews again. We talk about treating high blood pressure with CEO of George Medicines, Mark Mallon, and have a conversation with Jack Hoppin, CEO of Ratio Therapeutics, and John Babich, CSO, about the field of radiotherapeutics.
Blood pressure
Nearly half of US adults have high blood pressure and despite all the treatments already available, three in four remain uncontrolled. This is often because the tradi...
This week, we have two interviews. We chat with Step Pharma CEO, Andy Parker, and also have a conversation with Re-Vana CEO, Michael O’Rourke.
Ocular therapeutics
Re-Vana Therapeutics and Boehringer Ingelheim recently announced a $1bn+ deal to develop long-acting ophthalmic therapies.
Re-Vana Therapeutics is a privately held, US and UK based developer of ocular therapeutics and innovative ocular drug delivery technologies which spun o...
Base to Base biotech podcast 27: Childhood Cancer Awareness Month and DNA-based technology platforms
This week, we have two interviews: one to mark Childhood Cancer Awareness Month, on osteosarcoma with Paul Romness from OS Therapies; and IMUNON’s CEO, Stacy Lindborg, talking about ovarian cancer, immunotherapy, covid, and more.
Interview times:
02:33 OS Therapies
23:03 IMUNON
Challenging osteosarcoma
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialisation of treatments for os...
This week, we have three interviews to mark Stand Up To Cancer Day. We have conversations with Simon Kerry, co-founder and CEO of Curve Therapeutics; Poolbeg Pharma CEO Jeremy Skillington; and Stefano Gulla, CSO of Kling Biotherapeutics.
Interview times:
03:12 Curve Therapeutics
21:32 Kling Bio
37:10 Poolbeg Pharma
Microcycles to address cancer
Curve Therapeutics, a private biotechnology company using its gene-encoded Microcycle discover...
This week, we have an in-depth conversation on molecular glue degradation, with Monte Rosa Therapeutics’ chief data and information officer John Castle.
Interview time:
03:52 Monte Rosa Therapeutics
Molecular glue degradation
A recent cover article in Science showcased research that expands by more than 1,000 the number of therapeutic targets (including undruggables) accessible through a protein degradation approach known as molecular ...
This week, we look at Herantis Pharma's work on Parkinson's disease, with the company's CEO, Antti Vuolanto, and we have an in-depth look at the recent cuts to mRNA vaccine projects, with Jean Peccoud, GenoFAB founder and professor at Colorado State University.
Interview times:
03:22 Herantis
16:28 mRNA cuts
Cuts to mRNA vaccine projects
The U.S. Department of Health and Human Services (HHS) recently announced a major shift in its vacci...
This week, we have a wide-ranging conversation with Anna Codina, senior director strategy and business development at SciY (part of Bruker), as we discuss artificial intelligence, and digitalisation, and the effect on labs. We also chat with Fibrobiologics’ CEO Pete O'Heeron about fibroblast spheroid technology.
Interview times:
03:49 FibroBiologics
21:26 SciY
SciY on the path to digitalisation
This week, we have a wide-ranging conversa...
This week, we talk about new treatments for wet dry age-related macular degeneration (AMD) with Judith Greciet, CEO of PulseSight Therapeutics, and there’s a conversation with Maite Agüeros, CEO and co-founder of InnoUp Farma about, among other things, peanut allergies.
Interview times:
03:24 PulseSight
20:43 InnoUp
Tackling dry AMD
PulseSight Therapeutics SAS, an ophthalmology biotech company developing non-viral vectorised therapies...
This week, we talk about drug discovery with Shinya Yuki, co-founder and CEO of Elix Inc., and Teresa Whalen, CEO of CytoAgents, about CAR-T therapies, cytokine release syndrome, and the FDA.
Interview times:
03:53 Elix
20:58 CytoAgents
Elix drug discovery platform
AI drug discovery company Elix, Inc. and the Life Intelligence Consortium (LINC) have announced that for the first time in the world, an AI drug discovery platform has b...
This week, our conversations are with Wenyan Leong, director of APAC commercial and global strategic partnerships for cell and gene therapies at Terumo Blood and Cell Technologies, and Morten Graugaard, CEO of Orbis Medicines.
Interview times:
04:01 Terumo BCT
24:52 Orbis Medicines
Terumo Blood and Cell Technologies shows integrated 3-in-1 CAR-T workflow with quantum platform
Terumo Blood and Cell Technologies, (Terumo BCT), a medical...
This week’s podcast is sponsored by Nipro.
This week, our conversations are with Jesus Garcia, Nipro Product Manager Water Treatment, on Nipro ’s recently-launched product LiniXia, a reverse osmosis (RO) system that ensures safe and pure water for every dialysis session, and on the future of biologics manufacturing with cell-free protein synthesis with LenioBio CEO André Goerke.
Interview times:
05:16 Nipro
15:52 LenioBio
NIPRO
Nipro Me...
This week, we have conversations with Eduardo Bravo, CEO of Citryll, and Dermot Tierney, COO of AMPLY Discovery.
Interview times:
02:53 Citryll
21:56 AMPLY Discovery
Citryll
Citryll’s recent Series B financing of €85m at the end of last year is helping to advance its first-in-class therapy targeting neutrophil extracellular traps (NETs).
Discovered in 2004, NETs are web-like structures released by white blood cells that are now understoo...
Popular Podcasts
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
In 1997, actress Kristin Davis’ life was forever changed when she took on the role of Charlotte York in Sex and the City. As we watched Carrie, Samantha, Miranda and Charlotte navigate relationships in NYC, the show helped push once unacceptable conversation topics out of the shadows and altered the narrative around women and sex. We all saw ourselves in them as they searched for fulfillment in life, sex and friendships. Now, Kristin Davis wants to connect with you, the fans, and share untold stories and all the behind the scenes. Together, with Kristin and special guests, what will begin with Sex and the City will evolve into talks about themes that are still so relevant today. "Are you a Charlotte?" is much more than just rewatching this beloved show, it brings the past and the present together as we talk with heart, humor and of course some optimism.
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
The Clay Travis and Buck Sexton Show. Clay Travis and Buck Sexton tackle the biggest stories in news, politics and current events with intelligence and humor. From the border crisis, to the madness of cancel culture and far-left missteps, Clay and Buck guide listeners through the latest headlines and hot topics with fun and entertaining conversations and opinions.
Does hearing about a true crime case always leave you scouring the internet for the truth behind the story? Dive into your next mystery with Crime Junkie. Every Monday, join your host Ashley Flowers as she unravels all the details of infamous and underreported true crime cases with her best friend Brit Prawat. From cold cases to missing persons and heroes in our community who seek justice, Crime Junkie is your destination for theories and stories you won’t hear anywhere else. Whether you're a seasoned true crime enthusiast or new to the genre, you'll find yourself on the edge of your seat awaiting a new episode every Monday. If you can never get enough true crime... Congratulations, you’ve found your people. Follow to join a community of Crime Junkies! Crime Junkie is presented by audiochuck Media Company.